Single Nuclei Sequencing in Human Skeletal Muscle After Unloading
ULLS23
1 other identifier
interventional
20
1 country
1
Brief Summary
Injuries often require people to undergo some degree of limb immobilization. This comes at a high cost in terms of muscle mass and function losses. At the molecular level, it is completely unknown how the different cells in the muscle respond to this complete lack of mechanical stimuli. The investigators will explore cell type specific changes in skeletal muscle after a short period of unloading, and specifically examine the behavior of myogenic stem cells with particular attention to potential unloading-induced maturation into fast- or slow-twitch muscle fibers. Twenty healthy young participants will perform a 5-day Unilateral Lower Limb Suspension (ULLS) intervention, where one leg is continuously subjected to unloading, i.e., lack of mechanical stimuli. Before and after the ULLS period, participants will perform muscle function testing and MRI scans to assess muscle size in the lower limbs. Immediately after the ULLS, two muscle biopsies will be obtained, one from each leg. The tissue will be employed for single-nuclei RNA sequencing analysis and immunohistochemistry experiments. This project will be the first to analyze cell type specific changes induced by complete, short-term lack of mechanical stimuli in skeletal muscle. This will add a new dimension to the understanding of the processes directing this type of muscle atrophy (i.e., muscle loss in otherwise healthy individuals) and thus help to develop effective countermeasures to offset muscle changes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 5, 2023
CompletedFirst Submitted
Initial submission to the registry
March 13, 2023
CompletedFirst Posted
Study publicly available on registry
April 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedJuly 31, 2026
August 1, 2025
3.3 years
March 13, 2023
July 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Single nuclei RNA sequencing
Single nuclei RNA sequencing from skeletal muscle (m. vastus lateralis) from both legs
Immediately after the 5-day unilateral unloading intervention
Secondary Outcomes (3)
Muscle mass
Before and immediately after the 5-day unloading intervention
Concentric isokinetic torque of knee extensor muscles
Before and immediately after the 5-day unloading intervention
Isometric torque of knee extensor muscles
Before and immediately after the 5-day unloading intervention
Study Arms (1)
Unilateral lower limb suspension
EXPERIMENTALParticipants will perform a 5-day unloading intervention using the ULLS model. Short-length crutches, aided by handgrip and forearm support distal to the elbow will be used to assist in any upright or ambulatory activity. One foot (randomized in a counterbalance manner) will be equipped with a shoe having a 10-cm thick sole, which permits the unloaded limb to move passively about the hip joint while adopting a near straight position.
Interventions
Participants will perform a 5-day unloading intervention using the ULLS model. Short-length crutches, aided by handgrip and forearm support distal to the elbow will be used to assist in any upright or ambulatory activity. One foot (randomized in a counterbalance manner) will be equipped with a shoe having a 10-cm thick sole, which permits the unloaded limb to move passively about the hip joint while adopting a near straight position.
Eligibility Criteria
You may qualify if:
- Healthy young adult men and women
You may not qualify if:
- An age younger than 18 or older than 40 years
- Contraindications to magnetic resonance imaging (MRI)
- Contraindications to maximal intensity resistance exercise
- Contraindications to unloading (i.e., ULLS)
- Very high physical activity levels (determined using a standard Godin Leisure-Time Exercise Questionnaire (GLTEQ))
- Hypertension (\>140/90 mm Hg)
- History of malignancy
- History of coagulation dysfunction
- History of musculoskeletal or neurological disorders
- History of cardiovascular disease
- History of cerebrovascular disease
- History of respiratory disease
- History of gastrointestinal disease
- History of renal disease
- History of past or present condition requiring long-term drug prescriptions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Karolinska Institutet
Huddinge, Stockholm County, 14152, Sweden
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD and docent (Associate Professor)
Study Record Dates
First Submitted
March 13, 2023
First Posted
April 6, 2023
Study Start
March 5, 2023
Primary Completion
July 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
July 31, 2026
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share